Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Foundation Medicine, a molecular information company, has received the Clinical Laboratory Improvement Amendments (CLIA) certification for its genomic sequencing laboratory in Cambridge, Massachusetts.
Subscribe to our email newsletter
This certification will allow the company to accept clinical samples from most US states.
Foundation Medicine achieved Massachusetts State licensing in October 2011, enabling the company to begin processing clinical samples from most states.
The company has begun accepting clinical samples and expects to commercially launch its fully informative genomic profile for all patients with solid tumors in mid-2012.
Foundation Medicine COO Kevin Krenitsky said CLIA certification is a critical step that enables them to accept and report on clinical samples as they scale for full commercial launch later in 2012.
"Foundation Medicine has been dedicated to exceptional standards of operational performance from day one, and that quality commitment was evident in our clinical laboratory certification process," Krenitsky added.